OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Function and inhibition of Haspin kinase: targeting multiple cancer therapies by antimitosis
Yongjian Liu, Hongliu Yang, Yongsheng Fang, et al.
Journal of Pharmacy and Pharmacology (2022) Vol. 75, Iss. 4, pp. 445-465
Closed Access | Times Cited: 4
Yongjian Liu, Hongliu Yang, Yongsheng Fang, et al.
Journal of Pharmacy and Pharmacology (2022) Vol. 75, Iss. 4, pp. 445-465
Closed Access | Times Cited: 4
Showing 4 citing articles:
Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties
Wisam Taher Muslim, Layth Jasim Mohammed, M. Naji, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Wisam Taher Muslim, Layth Jasim Mohammed, M. Naji, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Iga Kołodziejczak-Guglas, Renan Simões, Emerson de Souza Santos, et al.
Cell Genomics (2025), pp. 100851-100851
Open Access
Iga Kołodziejczak-Guglas, Renan Simões, Emerson de Souza Santos, et al.
Cell Genomics (2025), pp. 100851-100851
Open Access
N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents
Noha Mostafa, Po‐Jen Chen, Sarah S. Darwish, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2033-2033
Open Access | Times Cited: 2
Noha Mostafa, Po‐Jen Chen, Sarah S. Darwish, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2033-2033
Open Access | Times Cited: 2
GSG2 promotes progression of human endometrial cancer by regulating PD-1/PD-L1 expression via PI3K-AKT pathway
Hong Chen, Shuxi Liu, Sikao Wu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112196-112196
Closed Access
Hong Chen, Shuxi Liu, Sikao Wu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112196-112196
Closed Access
